Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
Pregnancy and associated physiologic changes affect the pharmacokinetics of many medications, including selective serotonin reuptake inhibitors-the first-line pharmacologic interventions for depressive and anxiety disorders. During pregnancy, SSRIs exhibit extensive pharmacokinetic variability that...
Saved in:
Main Authors: | Ethan A. Poweleit (Author), Margaret A. Cinibulk (Author), Sarah A. Novotny (Author), Melissa Wagner-Schuman (Author), Laura B. Ramsey (Author), Jeffrey R. Strawn (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
by: Jeffrey R. Strawn, et al.
Published: (2021) -
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019) -
Talking 'bout digitality
by: Stefan Meier, et al.
Published: (2023) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing
by: Zachary L. Taylor, et al.
Published: (2023)